Woodline Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-45,370
Closed -$1.06M – 684
2023
Q1
$1.06M Buy
+45,370
New +$1.3M 0.01% 467
2021
Q3
– Sell
-36,210
Closed -$4.5M – 706
2021
Q2
$4.5M Buy
36,210
+9,997
+38% +$1.34M 0.08% 234
2021
Q1
$4M Buy
26,213
+2,370
+10% +$358K 0.09% 211
2020
Q4
$3.07M Buy
+23,843
New +$2.74M 0.08% 181

Other funds holding GH

Woodline Partners's GH Position: Q2 2023 in Review

Woodline Partners sold out of Guardant Health (GH) in Q2 2023, closing a stake of 45,370 shares — an estimated $1.06M sold.

Woodline Partners first reported a position in GH in Q4 2020 and held it in 4 quarters. The position peaked at $4.5M in Q2 2021. 299 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Woodline Partners reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Woodline Partners sold 45,370 Guardant Health shares in Q2 2023, an estimated $1.06M.
  • Woodline Partners first reported a position in Guardant Health in Q4 2020 and held it in 4 quarters.
  • Woodline Partners's Guardant Health position peaked at $4.5M in Q2 2021.
  • 299 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.